Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry

Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim

Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021

DOI: https://doi.org/10.3350/cmh.2020.0292

View: 6992 Download: 309 Web of Science: 31 Crossref: 33

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation

Hyeyoung Kim, Nam-Joon Yi, Juyeun Lee, Joohyun Kim, Mi-Ra Moon, Jaehong Jeong, Jeong-Moo Lee, Tae Suk You, Suk-Won Suh, Min-Su Park, YoungRok Choi, Geun Hong, Hae Won Lee, Kwang-Woong Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2014;20(3):291-299. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.291

View: 9392 Download: 95 Web of Science: 6 Crossref: 10

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2014;20(2):192-203. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.192

View: 9606 Download: 95 Web of Science: 23 Crossref: 22

1 |

Viewed By 5688	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4963	MAFLD: How is it different from NAFLD?
Viewed By 4723	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3833	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3823	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search